Evidence map›Paper›PMID 28157192›Full record

ArticleScientific reports2017

Unravelling the genetic basis of simplex Retinitis Pigmentosa cases.

Nereida Bravo-Gil, María González-Del Pozo, Marta Martín-Sánchez, Cristina Méndez-Vidal, Enrique Rodríguez-de la Rúa, Salud Borrego, Guillermo Antiñolo

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04751058 (Genetic Profile in Patients With Aortic Syndrome), which is not on this map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04751058 completednot on this mapstarted 2021, after this paper: background citation

Genetic Profile in Patients With Aortic Syndrome

TypeobservationalSponsorHospitales Universitarios Virgen del RocíoRan2021 to 2022Enrolled73ConditionsGene Abnormality, Acute Aortic SyndromeArmsgenetic analysis
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Atypical retinitis pigmentosa associated withAmerican journal of ophthalmology case reports · 2026
    Article
  3. Review
  4. Article
  5. Insights IntoHuman mutation · 2026
    Review
  6. Single-Cell Transcriptomics onBiomedicines · 2025
    Article
  7. BiallelicInternational journal of molecular sciences · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. "ArmedFrontiers in cell and developmental biology · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Clinical applications of gene therapy for rare diseases: A review.International journal of experimental pathology · 2023
    Review
  18. Clinical and Molecular Aspects of C2orf71/PCARE in Retinal Diseases.International journal of molecular sciences · 2023
    Review
  19. Article
  20. Modeling Retinitis Pigmentosa with Patient-Derived iPSCs.Advances in experimental medicine and biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Nereida Bravo-GilDepartment of Genetics, Reproduction and Fetal Medicine, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
María González-Del PozoDepartment of Genetics, Reproduction and Fetal Medicine, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
Marta Martín-SánchezDepartment of Genetics, Reproduction and Fetal Medicine, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
Cristina Méndez-VidalDepartment of Genetics, Reproduction and Fetal Medicine, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
Enrique Rodríguez-de la RúaDepartment of Ophthalmology, University Hospitals Virgen Macarena and Virgen del Rocío, Seville, Spain.
Salud BorregoDepartment of Genetics, Reproduction and Fetal Medicine, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
Guillermo AntiñoloDepartment of Genetics, Reproduction and Fetal Medicine, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
Centre for Biomedical Network Research on Rare Diseases · ESInstituto de Biomedicina de Sevilla · ESHospital Universitario Virgen Macarena · ESUniversidad de Sevilla · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinitis Pigmentosa (RP) is the most common form of inherited retinal dystrophy (IRD) characterized ultimately by photoreceptors degeneration. Exhibiting great clinical and genetic heterogeneity, RP can be inherited as an autosomal dominant (ad), autosomal recessive (ar) and X-linked (xl) disorder. Although the relative prevalence of each form varies somewhat between populations, a major proportion (41% in Spain) of patients represent simplex cases (sRP) in which the mode of inheritance is unknown. Molecular genetic diagnostic is crucial, but also challenging, for sRP patients because any of the 81 RP genes identified to date may be causative. Herein, we report the use of a customized targeted gene panel consisting of 68 IRD genes for the molecular characterization of 106 sRP cases. The diagnostic rate was 62.26% (66 of 106) with a proportion of clinical refinements of 30.3%, demonstrating the high efficiency of this genomic approach even for clinically ambiguous cases. The high number of patients diagnosed here has allowed us to study in detail the genetic basis of the sRP. The solved sRP cohort is composed of 62.1% of arRP cases, 24.2% of adRP and 13.6% of xlRP, which implies consequences for counselling of patients and families.

Indexed as

Genetic Predisposition to DiseaseFemaleGenetic LociGenome-Wide Association StudyHumansMalePedigreeRetinitis Pigmentosa

Identifiers

PMID28157192
PMCPMC5291209
OpenAlexW2585468109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.